WuXi Bio gains some trac­tion in Eu­rope in the face of Biose­cure threat in the US

10 months ago
China
Manufacturing

FDA ap­proves Citius Phar­ma's non-Hodgkin lym­phoma drug Lym­phir

10 months ago
Pharma
FDA+

Lil­ly’s an­ti-tau pill for Alzheimer’s fails in Phase 2 study

10 months ago
R&D

Apel­lis and So­bi land an­oth­er late-stage win for rare kid­ney dis­ease drug

10 months ago
R&D

Am­neal Phar­ma's ex­tend­ed-re­lease Park­ison's treat­ment clinch­es FDA ap­proval

10 months ago
Pharma
FDA+

In­tel­lia’s gene edit­ing ther­a­py suc­ceeds in Phase 2 ge­net­ic swelling con­di­tion study

10 months ago
R&D

TIG­IT drugs take an­oth­er hit as Mer­ck stops Phase 3 lung can­cer tri­al for fu­til­i­ty

10 months ago
R&D

Q&A: PhRMA CEO Stephen Ubl on the IRA, chal­lenges to the FDA’s au­thor­i­ty and the US-Chi­na re­la­tion­ship

10 months ago
People
Pharma

Roivant to 'un­veil' pipeline ad­di­tion next month; Bavar­i­an Nordic gets $156M from US

10 months ago
News Briefing

Up­dat­ed: Re­cur­sion to ac­quire Ex­sci­en­tia to bol­ster pipeline in one of AI bio’s biggest M&A deals

10 months ago
Deals
AI

En­tero Ther­a­peu­tics turns the lights off as cred­i­tors come call­ing

10 months ago
People

Lil­ly crush­es ex­pec­ta­tions with GLP-1 fran­chise, as sup­ply con­straints ease

10 months ago
Pharma
Manufacturing

UK's NHS, Ver­tex strike pact, ac­cel­er­at­ing Cas­gevy roll­out in be­ta tha­lassemia

10 months ago
Pharma

FDA ap­proves No­var­tis’ com­ple­ment in­hibitor Fab­hal­ta for rare kid­ney dis­ease

10 months ago
Pharma
FDA+

Sanofi’s Sar­clisa scores in Phase 3 trans­plant-el­i­gi­ble mul­ti­ple myelo­ma test

10 months ago
R&D

Sarep­ta faces low­er rev­enue for Duchenne gene ther­a­py ahead of ex­pect­ed sales jump with ex­pand­ed treat­ment la­bel

10 months ago
Pharma

Os­car Health's guid­ance gets a boost from ex-Med­ic­aid mem­bers

10 months ago
Health Tech

Health in­sur­ers are cov­er­ing few­er tele­health com­pa­nies, Talk­space says

10 months ago
Health Tech

FDA rep­ri­mands Bris­tol My­ers over mis­lead­ing ef­fi­ca­cy claims on Kraza­ti web­site

10 months ago
Pharma
FDA+

UPenn sues BioN­Tech, says it owes 'sig­nif­i­can­t' Covid-re­lat­ed roy­al­ties

10 months ago
Pharma
Law

Big drug­mak­ers have cut out­side R&D spend­ing amid broad pull­back, key con­trac­tor warns

10 months ago
Pharma
Manufacturing

FDA grap­ples with its role in AI, and how to guide in­dus­try's adop­tion

10 months ago
R&D
AI

CVS ousts Aet­na pres­i­dent as it tries to fix its health in­sur­ance busi­ness

10 months ago
Health Tech

IDRx rais­es $120M for tar­get­ed GIST drug fol­low­ing lead­er­ship change

10 months ago
Financing
First page Previous page 119120121122123124125 Next page Last page
A service from the Financial Times